CAMCEVI

Medicinal product

(Invented) name

CAMCEVI

Active substance (s)

Leuprorelinas

Strength

21 mg

Pharmaceutical form

pailginto atpalaidavimo injekcinė suspensija

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L02AE02, Leuprorelin

Marketing authorisation holder

Accord Healthcare S.L.U., Ispanija

Date of authorisation

2022-05-24

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Užpildytame švirkšte yra	1 vnt.
Leuprorelinas	21 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120605	106709	1106709	užpildytas švirkštas	N1 (+adata su apsauga)		Receptinis	EU/1/22/1647/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-05-24	Registruotas